Consumer Advertisements: How To Spend $3.75 Billion

Article Abstract:

As a result of the relaxed FDA regulations on marketing drugs, between 1989 and 1997, direct-to-consumer advertising (DTCA) has risen from $13 million to $859.9 million. Allergy medications have experienced the highest increase in spending at about 25 percent of all DTCA marketing. Other drugs statistics are also mentioned.

Capital expenditures, Advertising, Direct Marketing, Statistical Data Included, Abstract

---

Drug discovery and diagnostic targets in synergy

Article Abstract:

Pharmaceutical companies spend much time and money in developing new products, but the FDA Modernization Act of 1997 may ease the regulatory process. The Genome Project may also quicken the pace of new drug development.

Product development

---

Not currently OTC--potential switches in therapeutic areas now Rx

Article Abstract:

The article discusses current prescription-only drugs and evaluates their potential as over-the-counter medications.

Product information

Similar abstracts:

• Abstracts: Treatment of hypertension in diabetic patients. Hypertension in the elderly
• Abstracts: ZymeTx: ZymeTx improves Flu Diagnostic Test. ZymeTx: shipments of flu diagnostic tests accelerate
• Abstracts: Monoclonal Antibodies - Development and Innovative Opportunities in Oncology. Diabetes, needs/gaps in current treatment
• Abstracts: Adverse selection and regulation in health insurance markets. The economics of regulatory mandates on the HMO market
• Abstracts: Creating a research base for nursing education: an interpretive review of conventional, critical, feminist, postmodern, and phenomenologic pedagogies

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.